To corroborate our findings, we interrogated RNA-seq from patients’ tissues and found that ZBED2 is the gene whose expression is more prominent in FGFR4 low tumours of the ICGC cohort (Supplementary Fig. 5A). This evidence concerns the gene FGFR4 and neoplasm.